Suchergebnisse - "Getz, Gad"

PubPharm (724)

41

Clonal origin of KMT2A wild-type lineage-switch leukemia following CAR-T cell and blinatumomab therapy

enthalten in: Nature cancer | 2023

von Coorens, T. | Collord, G. | Treger, T. | +7

42

Proteogenomic data and resources for pan-cancer analysis

enthalten in: Cancer cell | 2023

von Li, Y. | Dou, Y. | Da Veiga Leprevost, F. | +131

43

Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitors

enthalten in: bioRxiv.org | 2023

von Sklavenitis-Pistofidis, R. | Lightbody, E. | Reidy, M. | +17

44

CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers

enthalten in: Science (New York, N.Y.) | 2023

von Bill, R. | Wirapati, P. | Messemaker, M. | +30

45

Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples

enthalten in: Blood | 2023

von Khalsa, J. | Cha, J. | Utro, F. | +25

46

Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitors

enthalten in: bioRxiv : the preprint server for biology | 2023

von Sklavenitis-Pistofidis, R. | Lightbody, E. | Reidy, M. | +17

47

Clinical Importance of the lncRNA NEAT1 in Cancer Patients Treated with Immune Checkpoint Inhibitors

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Toker, J. | Iorgulescu, J. | Ling, A. | +8

48

Novel mechanism ofMYCderegulation in Multiple Myeloma

enthalten in: bioRxiv.org | 2023

von Rahmat, M. | Clement, K. | Alberge, J. | +11

49

Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer

enthalten in: Nature genetics | 2023

von Ravi, A. | Hellmann, M. | Arniella, M. | +39

50

Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance

enthalten in: Blood advances | 2023

von Naeem, A. | Utro, F. | Wang, Q. | +22

CommentIn: Blood Adv. 2023 May 9;7(9):1926-1928. - PMID 36355806